Role of angiotensin-converting enzyme 2 and angiotensin(1-7) in 17β-oestradiol regulation of renal pathology in renal wrap hypertension in rats

Experimental Physiology

Volumn 93, Issue 5, 2008, Pages 648-657

  Ji, Hong ^a   Menini, Stefano ^b   Zheng, Wei ^a   Pesce, Carlo ^b   Wu, Xie ^a   Sandberg, Kathryn ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN[1-7]; ESTRADIOL; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; FIBROSING ALVEOLITIS; GLOMERULOSCLEROSIS; HEART RATE; HIGH SODIUM INTAKE; HYPERTENSION; KIDNEY CORTEX; KIDNEY INJURY; MEAN ARTERIAL PRESSURE; NONHUMAN; OVARIECTOMY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; UPREGULATION;

EID: 42649144447     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2007.041392     Document Type: Article

References (47)

1. Benter I, Yousif M, Dhaunsi G, Kaur J, Chappell M & Diz D (2008). Angiotensin‐(1–7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats. Am J Nephrol 28, 25–33.
2. Brosnihan KB, Li P, Ganten D & Ferrario CM (1997). Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor‐vasodilator balance of RAS. Am J Physiol Regul Integr Comp Physiol 273, R1908–R1915.
3. Brosnihan KB, Neves LA, Joyner J, Averill DB, Chappell MC, Sarao R, Penninger J & Ferrario CM (2003). Enhanced renal immunocytochemical expression of ANG‐(1–7) and ACE2 during pregnancy. Hypertension 42, 749–753.
4. Brosnihan KB, Senanayake PS, Li P & Ferrario CM (1999). Bi‐directional actions of estrogen on the renin‐angiotensin system. Braz J Med Biol Res 32, 373–381.
5. Burns KD (2007). The emerging role of angiotensin‐converting enzyme‐2 in the kidney. Curr Opin Nephrol Hypertens 16, 116–121.
6. Chappell MC (2007). Emerging evidence for a functional angiotensin‐converting enzyme 2‐angiotensin‐(1–7)‐MAS receptor axis: more than regulation of blood pressure? Hypertension 50, 596–599.
7. Costa AP, Fagundes‐Moura CR, Pereira VM, Silva LF, Vieira MA, Santos RA & Dos Reis AM (2003). Angiotensin‐(1–7): a novel peptide in the ovary. Endocrinology 144, 1942–1948.
8. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, Oliveira‐dos‐Santos AJ, Da Costa J, Zhang L, Pei Y, Scholey J, Ferrario CM, Manoukian AS, Chappell MC, Backx PH, Yagil Y & Penninger JM (2002). Angiotensin‐converting enzyme 2 is an essential regulator of heart function. Nature 417, 822–828.
9. Danilczyk U & Penninger JM (2006). Angiotensin‐converting enzyme II in the heart and the kidney. Circ Res 98, 463–471.
10. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE & Acton S (2000). A novel angiotensin‐converting enzyme‐related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. [see comment] Circ Res 87, E1–E9.
11. Ferrari P (2007). Prescribing angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease. Nephrology 12, 81–89.
12. Grobe JL, Mecca AP, Lingis M, Shenoy V, Bolton TA, Machado JM, Speth RC, Raizada MK & Katovich MJ (2007). Prevention of angiotensin II‐induced cardiac remodeling by angiotensin‐(1–7). Am J Physiol Heart Circ Physiol 292, H736–H742.
13. Grollman A (1944). A simplified procedure for inducing chronic renal hypertension in the mammal. Proc Soc Exp Biol Med 57, 102–104.
14. Gurley SB, Allred A, Le TH, Griffiths R, Mao L, Philip N, Haystead TA, Donoghue M, Breitbart RE, Acton SL, Rockman HA & Coffman TM (2006). Altered blood pressure responses and normal cardiac phenotype in ACE2‐null mice. J Clin Invest 116, 2218–2225.
15. Harrison‐Bernard LM, Schulman IH & Raij L (2003). Postovariectomy hypertension is linked to increased renal AT 1 receptor and salt sensitivity. Hypertension 42, 1157–1163.
16. Hinojosa‐Laborde C, Craig T, Zheng W, Ji H, Haywood JR & Sandberg K (2004). Ovariectomy augments hypertension in aging female Dahl salt‐sensitive rats. Hypertension 44, 1–5.
17. Hinojosa‐Laborde C, Guerra P & Haywood JR (1992). Sympathetic nervous system in high sodium one‐kidney, figure‐8 renal hypertension. Hypertension 20, 96–102.
18. Ji H, Menini S, Mok K, Zheng W, Pesce C, Kim J, Mulroney S & Sandberg K (2005a). Gonadal steroid regulation of renal injury in renal wrap hypertension. Am J Physiol Renal Physiol 288, F513–F520.
19. Ji H, Pesce C, Menini S, Wu X, Zheng W & Sandberg K (2006). 17β‐Estradiol‐mediated protection from renal injury is associated with up regulation of angiotensin converting enzyme 2 (ACE2). Hypertension 48, E28.
20. Ji H, Pesce C, Zheng W, Kim J, Zhang Y, Menini S, Haywood JR & Sandberg K (2005b). Sex differences in renal injury and nitric oxide production in renal wrap hypertension. Am J Physiol Heart Circ Physiol 288, H43–H47.
21. Ji H, Zheng W, Falconetti C, Roesch DM, Mulroney SE & Sandberg K (2007a). 17β‐Estradiol deficiency reduces potassium excretion in an angiotensin type 1 receptor‐dependent manner. Am J Physiol Heart Circ Physiol 293, H17–H22.
22. Ji H, Zheng W, Menini S, Pesce C, Kim J, Wu X, Mulroney SE & Sandberg K (2007b). Female protection in progressive renal disease is associated with estradiol attenuation of superoxide production. [see comment] Gender Med 4, 56–71.
23. Joyner J, Neves LA, Granger JP, Alexander BT, Merrill DC, Chappell MC, Ferrario CM, Davis WP & Brosnihan KB (2007). Temporal‐spatial expression of ANG‐(1–7) and angiotensin‐converting enzyme 2 in the kidney of normal and hypertensive pregnant rats. Am J Physiol Regul Integr Comp Physiol 293, R169–R177.
24. Li N, Zimpelmann J, Cheng K, Wilkins JA & Burns KD (2005). The role of angiotensin converting enzyme 2 in the generation of angiotensin 1–7 by rat proximal tubules. Am J Physiol Renal Physiol 288, F353–F362.
25. Lombet JR, Adler SG, Anderson PS, Nast CC, Olsen DR & Glassock RJ (1989). Sex vulnerability in the subtotal nephrectomy model of glomerulosclerosis in the rat. J Lab Clin Med 114, 66–74.
26. Maric C, Sandberg K & Hinojosa‐Laborde C (2004). Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17β‐estradiol in the aging Dahl salt sensitive rat. J Am Soc Nephrol 15, 1546–1556.
27. Mok K‐Y, Sandberg K, Sweeny JM, Zheng W, Lee S & Mulroney SE (2003). Growth hormone regulation of glomerular AT1 angiotensin receptors in adult uninephrectomized male rats. Am J Physiol Renal Physiol 285, F1085–F1091.
28. Neugarten J, Acharya A & Silbiger SR (2000). Effect of gender on the progression of nondiabetic renal disease: a meta‐analysis. J Am Soc Nephrol 11, 319–329.
29. Okuniewski R, Davis EA, Jarrott B & Widdop RE (1998). A comparison of the development of renal hypertension in male and female rats. Clin Sci 95, 445–451.
30. Oudit GY, Herzenberg AM, Kassiri Z, Wong D, Reich H, Khokha R, Crackower MA, Backx PH, Penninger JM & Scholey W (2006). Loss of angiotensin‐converting enzyme‐2 leads to the development of angiotensin II‐dependent glomerulosclerosis. Am J Physiol 168, 1808–1820.
31. Owonikoko TK, Fabucci ME, Brown PR, Nisar N, Hilton J, Mathews WB, Ravert HT, Rauseo P, Sandberg K, Dannals RF & Szabo Z (2004). In vivo investigation of estrogen regulation of adrenal and renal angiotensin (AT 1) receptor expression by PET. J Nucl Med 45, 94–100.
32. Raizada MK & Ferreira AJ (2007). ACE2: a new target for cardiovascular disease therapeutics. J Cardiovasc Pharmacol 50, 112–119.
33. Ren Y, Garvin JL & Carretero OA (2002). Vasodilator action of angiotensin‐(1–7) on isolated rabbit afferent arterioles. Hypertension 39, 799–802.
34. Rogers JL, Mitchell AR, Maric C, Sandberg K, Myers A & Mulroney SE (2007). Effect of sex hormones on renal estrogen and angiotensin type 1 receptors in female and male rats. Am J Physiol Regul Integr Comp Physiol 292, R794–R799.
35. Shaltout HA, Westwood BM, Averill DB, Ferrario CM, Figueroa JP, Diz DI, Rose JC & Chappell MC (2007). Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2‐dependent processing of angiotensin II. Am J Physiol Renal Physiol 292, F82–F91.
36. Su Z, Zimpelmann J & Burns KD (2006). Angiotensin‐(1–7) inhibits angiotensin II‐stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int 69, 2212–2218.
37. Tomanek RJ & Aydelotte MR (1992). Late onset renal hypertension in old rats alters left ventricular structure and function. Am J Physiol Heart Circ Physiol 262, H531–H538.
38. Tomanek RJ, Aydelotte MR & Butters CA (1990). Late‐onset renal hypertension in old rats alters myocardial microvessels. Am J Physiol Heart Circ Physiol 259, H1681–H1687.
39. Trask AJ & Ferrario CM (2007). Angiotensin‐(1–7): pharmacology and new perspectives in cardiovascular treatments. Cardiovasc Drug Rev 25, 162–174.
40. Valdes G, Germain AM, Corthorn J, Berrios C, Foradori AC, Ferrario CM & Brosnihan KB (2001). Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation. Endocrine 16, 117–122.
41. Wakahara S, Konoshita T, Mizuno S, Motomura M, Aoyama C, Makino Y, Kato N, Koni I & Miyamori I (2007). Synergistic expression of angiotensin‐converting enzyme (ACE) and ACE2 in human renal tissue and confounding effects of hypertension on the ACE to ACE2 ratio. Endocrinology 148, 2453–2457.
42. Welch WJ, Chabrashvili T, Solis G, Chen Y, Gill PS, Aslam S, Wang X, Ji H, Sandberg K, Jose P & Wilcox CS (2006). Role of extracellular superoxide dismutase in the mouse angiotensin slow pressor response. [see comment] Hypertension 48, 934–941.
43. Wenzel RR (2005). Renal protection in hypertensive patients: selection of antihypertensive therapy. Drugs 65 (Suppl 2), 29–39.
44. Wong DW, Oudit GY, Reich H, Kassiri Z, Zhou J, Liu QC, Backx PH, Penninger JM, Herzenberg AM & Scholey JW (2007). Loss of angiotensin‐converting enzyme‐2 (Ace2) accelerates diabetic kidney injury. Am J Pathol 171, 438–451.
45. Wysocki J, Ye M, Soler MJ, Gurley SB, Xiao HD, Bernstein KE, Coffman TM, Chen S & Batlle D (2006). ACE and ACE2 activity in diabetic mice. Diabetes 55, 2132–2139.
46. Ye M, Wysocki J, William J, Soler MJ, Cokic I & Batlle D (2006). Glomerular localization and expression of Angiotensin‐converting enzyme 2 and Angiotensin‐converting enzyme: implications for albuminuria in diabetes. [see comment] J Am Soc Nephrol 17, 3067–3075.
47. Zhong JC, Huang DY, Yang YM, Li YF, Liu GF, Song XH & Du K (2004). Upregulation of angiotensin‐converting enzyme 2 by all‐ trans retinoic acid in spontaneously hypertensive rats. Hypertension 44, 907–912.